-transparent.png){kind=logo}
A case of haemophagocytic lymphohistiocytosis consistent with X-linked lymphoproliferative disorder is described. Remission was observed after administration of VP-213, a cytotoxic drug generally used to treat histiocytosis. The child is currently in good clinical health.
Related Publications
R Migliorati, and
A Castaldo, and
S Russo, and
F Porta, and
A Fiorillo, and
S Guida, and
V Poggi, and
A Guarino
January 1985,
Haematology and blood transfusion,
R Migliorati, and
A Castaldo, and
S Russo, and
F Porta, and
A Fiorillo, and
S Guida, and
V Poggi, and
A Guarino
January 1982,
Cancer chemotherapy and pharmacology,
R Migliorati, and
A Castaldo, and
S Russo, and
F Porta, and
A Fiorillo, and
S Guida, and
V Poggi, and
A Guarino
December 1995,
Transplantation proceedings,
R Migliorati, and
A Castaldo, and
S Russo, and
F Porta, and
A Fiorillo, and
S Guida, and
V Poggi, and
A Guarino
May 1980,
Cancer,
R Migliorati, and
A Castaldo, and
S Russo, and
F Porta, and
A Fiorillo, and
S Guida, and
V Poggi, and
A Guarino
November 2008,
Neurology,
R Migliorati, and
A Castaldo, and
S Russo, and
F Porta, and
A Fiorillo, and
S Guida, and
V Poggi, and
A Guarino
February 2004,
Annals of hematology,
R Migliorati, and
A Castaldo, and
S Russo, and
F Porta, and
A Fiorillo, and
S Guida, and
V Poggi, and
A Guarino
January 1982,
Cancer chemotherapy and pharmacology,
R Migliorati, and
A Castaldo, and
S Russo, and
F Porta, and
A Fiorillo, and
S Guida, and
V Poggi, and
A Guarino
January 2004,
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
R Migliorati, and
A Castaldo, and
S Russo, and
F Porta, and
A Fiorillo, and
S Guida, and
V Poggi, and
A Guarino
August 1987,
Anti-cancer drug design,
R Migliorati, and
A Castaldo, and
S Russo, and
F Porta, and
A Fiorillo, and
S Guida, and
V Poggi, and
A Guarino
April 1988,
European journal of cancer & clinical oncology,
